GOVX - Beyond Meat Appian among premarket losers' pack

May, 07 2021 08:37 AM GeoVax Labs Inc.

ChemoCentryx (CCXI) -49% after FDA panel split 9-9 on efficacy for Chemocentryx's vasculitis candidate avacopan and reports outcome of FDA’s expert panel meeting on avacopan.Orphazyme (ORPH) -28% after arimoclomol flunks late-stage amyotrophic lateral sclerosis study.F-star Therapeutics (FSTX) -20% on pricing $65M stock offering.Centerra Gold (CGAU) -18%.Appian (APPN) -15% on Q1 earnings release.American Shared Hospital (AMS) -14%.AutoWeb (AUTO) -11% on Q1 earnings release.Stealth BioTherapeutics (MITO) -11%.PureCycle Technologies (PCT) -11% after new short report from Hindenburg Research (update).Aurinia Pharmaceuticals (AUPH) -11% on Q1 earnings release.JFrog (FROG) -10% on Q1 earnings release.Globalstar (GSAT) -10% on Q1 earnings release.ShiftPixy (PIXY) -9%.Beyond Meat (BYND) -8% on Q1 earnings release.SunLink Health Systems (SSY) -8%.Applied UV (AUVI) -8%.Charles & Colvard (CTHR) -7% on FQ3 earnings release.Waitr Holdings (WTRH) -6% on Q1 earnings release.Midatech Pharma (MTP) -6%.Drive Shack (DS) -6% on Q1 earnings release.GeoVax Labs (GOVX) -6% on Q1 earnings release.ENGlobal (ENG) -8% on Q1 earnings release.Athenex (ATNX) -5% on Q1 earnings release.Avinger (AVGR) -5% on Q1 earnings release.TD Holdings (GLG) -4%.

For further details see:

Beyond Meat, Appian among premarket losers' pack

Company Name:	GeoVax Labs Inc.
Stock Symbol:	GOVX
Market:	OTC
Website:	geovax.com

Twitter